# Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

> **NCT05548452** · PHASE1,PHASE2 · RECRUITING · sponsor: **Virginia Commonwealth University** · enrollment: 80 (estimated)

## Conditions studied

- Liver Disease; Alcohol-Related
- Cirrhosis
- Alcohol Use Disorder

## Interventions

- **DRUG:** Intestinal Microbiota Transplant (IMT) Capsules
- **DRUG:** Placebo Capsules

## Key facts

- **NCT ID:** NCT05548452
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-21
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05548452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05548452, "Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05548452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*